Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Other solid neoplasm 1Other neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Skin Neoplasms 1Skin Cancer Prevention 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Sunscreening Agents × Dermatologic × Clear all
NCT05736224 2024-11-27

Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen

Yale University

Phase 1 Completed
30 enrolled 6 charts
Dermatologic

Skin Neoplasms

NCT01804595 2014-05-20

A Randomized Control Trial of Sun Protection Interventions for Operating Engineers

University of Michigan

Phase 2/3 Completed
357 enrolled
Dermatologic

Skin Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡